SLGL

Sol-Gel Technologies Ltd. · NASDAQ · Healthcare · USD · 20-F for 2025, filed 2026-03-19

Figures on this page computed 2026-11-08 12:48 UTC

Last close

66.00USD

Market data, 2026-11-04

Except where said otherwise: 20-F for 2025, filed 2026-03-19

n/aP/E
We do not hold this figure for this company, so there is nothing to place.
Price / Earnings per Share (diluted)
Source
computed
Fiscal year
2025
Accession
0001178913-26-001552
Reported in
USD
- computed
- 20-F for 2025, filed 2026-03-19
The filing itself
n/aROIC
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Fiscal year
2025
Accession
0001178913-26-001552
Reported in
USD
- 20-F for 2025, filed 2026-03-19
- 20-F for 2025, filed 2026-03-19
- 20-F for 2025, filed 2026-03-19
- 20-F for 2025, filed 2026-03-19
- 20-F for 2025, filed 2026-03-19
- 20-F for 2025, filed 2026-03-19
The filing itself
-31.6%Net margin
Net Income / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0001178913-26-001552
Reported in
USD
- 20-F for 2025, filed 2026-03-19
- 20-F for 2025, filed 2026-03-19
The filing itself
1.4%FCF margin
Free Cash Flow / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0001178913-26-001552
Reported in
USD
- 20-F for 2025, filed 2026-03-19
- 20-F for 2025, filed 2026-03-19
The filing itself
n/aDebt/equity
We do not hold this figure for this company, so there is nothing to place.
Total Debt / Shareholders' Equity
Source
computed
Fiscal year
2025
Accession
0001178913-26-001552
Reported in
USD
- 20-F for 2025, filed 2026-03-19
- 20-F for 2025, filed 2026-03-19
The filing itself
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed

Price is the furthest below its sector's middle: 0.11 against 0.38 on the market's range.

What it pays out: n/aWe do not hold this figure for this company, so there is nothing to place.

Five bars, one line

lens 7 of 9

1.75x

0.32x

-0.02x

n/a

1.10x

SalesProfitFree cash flowDebtPrice

Each bar against this company's own average; the line is that average.

Filed2025

Market data2026-11-04

Each against its own average

4 of 5 read

Except where said otherwise: 20-F for 2025, filed 2026-03-19

Sales1.75x
Its own average over 9 years, 11.1M.
Profit0.32x
Its own average over 10 years, -19.4M.
Free cash flow-0.02x
Its own average over 10 years, -16.7M.
Debtn/a
Its own average over 2 years, 51.3M.
Price1.10x
Its own average over 9 years, 60. Market data, 2026-11-04

Free cash flow is furthest from its own average, at -0.02 times.

Sales is 1.75 times its own 9-year average; Profit is 0.32 times its own 10-year average; Free cash flow is -0.02 times its own 10-year average; Price is 1.10 times its own 9-year average.

Every figure in this lens

Except where said otherwise: 20-F for 2025, filed 2026-03-19

Sales against its own 9-year average1.75
Source
filed
Statement
income
Fiscal year
2025
Accession
0001178913-26-001552
Reported in
USD
The filing itself
Profit against its own 10-year average0.32
Source
filed
Statement
income
Fiscal year
2025
Accession
0001178913-26-001552
Reported in
USD
The filing itself
Free cash flow against its own 10-year average-0.02
Source
filed
Statement
income
Fiscal year
2025
Accession
0001178913-26-001552
Reported in
USD
The filing itself
Debt against its own 2-year averagen/a
Not held.
Source
filed
Statement
income
Fiscal year
2025
Accession
0001178913-26-001552
Reported in
USD
The filing itself
Price against its own 9-year average1.10Market data, 2026-11-04
Source
market
Taken on
2026-11-04
Reported in
USD